Company Presentation • 07 Nov 2019 21:00
Company Presentation • 27 Oct 2021 20:30
Company Presentation • 03 Feb 2022 21:30
Company Presentation • 31 Mar 2022 20:30
Company Presentation • 11 Sep 2023 20:30
ENTITY
InflaRx NV (IFRX US)
InflaRx NV (IFRX US)
9
Analysis
Health Care • United States
InflaRx N.V. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies drugs for the treatment of inflammatory diseases. InflaRx serves patients worldwide.
more
x